Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | HTR5A | P47898 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6557836 | 0.69 | MAP2K7 (0.31) | — | |
| SCHEMBL10103686 | 0.69 | TRPA1 (0.31) | — | |
| SCHEMBL31522793 | 0.69 | MAOA (0.31) | — | |
| SCHEMBL28536794 | 0.69 | — | — | |
| SCHEMBL9555406 | 0.69 | S100A4 (0.32) | TSHR | |
| SCHEMBL10111693 | 0.67 | — | — | |
| SCHEMBL12215976 | 0.65 | GAA (0.40) | TSHR | |
| SCHEMBL14606215 | 0.65 | — | — | |
| SCHEMBL12978432 | 0.64 | ACHE (0.39) | TSHRACHE | |
| SCHEMBL10872817 | 0.63 | PIM1 (0.34) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNIV ARIZONA STATE (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNIV ARIZONA STATE (US) | 2023-06-22 | — | — | US | disclosed |
| EP-3419971-B1 | GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2022-04-20 | — | — | EP | disclosed |
| US-20210024526-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNITED STATES DEPARTMENT OF ENERGY | 2021-01-28 | — | — | US | disclosed |
| US-10851106-B2 | Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-12-01 | — | — | US | disclosed |
| US-20200071330-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNITED STATES DEPARTMENT OF ENERGY | 2020-03-05 | — | — | US | disclosed |
| EP-3281936-B1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | SHANGHAI NICHEM FINE CHEMICAL CO LTD (CN) | 2019-10-09 | — | — | EP | disclosed |
| US-10392387-B2 | Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-08-27 | — | — | US | disclosed |
| US-20170362211-A1 | SMALL MOLECULE INHIBITORS OF FIBROSIS | THE SCRIPPS RESEARCH INSTITUTE | 2017-12-21 | — | — | US | disclosed |
| US-20170342102-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | US | disclosed |
| WO-2017173358-A1 | OXYSTEROLS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS, INC. (US) | 2017-10-05 | — | — | WO | disclosed |
| US-20170247405-A1 | OXYSTEROLS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS, INC. | 2017-08-31 | — | — | US | disclosed |
| US-20170233433-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2017-08-17 | — | — | US | disclosed |
| CN-103568583-B | Useless cartridge, ink-jet recording apparatus and useless black recovery method | KYOCERA DOCUMENT SOLUTIONS INC (JP) | 2015-10-07 | — | — | CN | disclosed |
| CN-103568583-A | Ink jet recording device, waste ink tray, and waste ink collecting method using waste ink tray | KYOCERA DOCUMENT SOLUTIONS INC | 2014-02-12 | — | — | CN | disclosed |
| US-20120165335-A1 | CDK INHIBITORS | CURIS, INC. | 2012-06-28 | — | — | US | disclosed |
| WO-2009035031-A1 | PAINT FOR LIVESTOCK MAT AND FLOOR OF LIVESTOCK HOUSE | IDEMITSU KOSAN CO., LTD. (JP) | 2009-03-19 | — | — | WO | disclosed |
| US-20080138385-A1 | Antibacterial Composition, Antibacterial Molding, Solution Containing Antibacterial Composition, Detergent, Surface of Tatami Mat and Tatami Mat | IDEMITSU TECHNOFINE CO., LTD. (JP) | 2008-06-12 | — | — | US | disclosed |
| US-20080053134-A1 | Air Conditioner | DAIKIN INDUSTRIES, LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| EP-1840475-A1 | AIR CONDITIONER | Daikin Industries, Ltd. (JP) | 2007-10-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024526-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | NOS2 3525/4885NOS3 3486/4885HTR5A 629/4885 |
| US-20080138385-A1 | Antibacterial Composition, Antibacterial Molding, Solution Containing Antibacterial Composition, Detergent, Surface of Tatami Mat and Tatami Mat | TPMT, KAT5, CARM1 | NOS2 799/4885NOS3 671/4885HTR5A 4279/4885 |
| US-20170233433-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | GRIN2B, AVPR1B, GRIN2A | NOS2 1403/4885NOS3 1381/4885HTR5A 334/4885 |
| US-20200071330-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | NOS2 3525/4885NOS3 3486/4885HTR5A 629/4885 |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | NOS2 3525/4885NOS3 3486/4885HTR5A 629/4885 |
| US-10851106-B2 | Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials | KCNK4, TRPC4, TBRG4 | NOS2 4637/4885NOS3 4690/4885HTR5A 53/4885 |
| US-20120165335-A1 | CDK INHIBITORS | CDK3, CDK6, CDKL1 | NOS2 4328/4885NOS3 4403/4885HTR5A 3703/4885 |
| US-10392387-B2 | Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials | NT5C, HTR3D, IK | NOS2 3468/4885NOS3 3432/4885HTR5A 15/4885 |
| US-20170247405-A1 | OXYSTEROLS AND METHODS OF USE THEREOF | NR1H3, NR1H2, HSD17B7 | NOS2 522/4885NOS3 403/4885HTR5A 1012/4885 |
| US-20170362211-A1 | SMALL MOLECULE INHIBITORS OF FIBROSIS | MMP1, COL2A1, MMP8 | NOS2 819/4885NOS3 762/4885HTR5A 4801/4885 |
| US-20170342102-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | GRIN2B, ADRA2B, ADRA1B | NOS2 1428/4885NOS3 1534/4885HTR5A 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.